The latest price target for BioSig Technologies (NASDAQ:BSGM) was reported by Ascendiant Capital on December 5, 2024. The analyst firm set a price target for $2.75 expecting BSGM to rise to within 12 months (a possible 111.54% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for BioSig Technologies (NASDAQ:BSGM) was provided by Ascendiant Capital, and BioSig Technologies maintained their buy rating.

There is no last upgrade for BioSig Technologies

There is no last downgrade for BioSig Technologies.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioSig Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioSig Technologies was filed on December 5, 2024 so you should expect the next rating to be made available sometime around December 5, 2025.

While ratings are subjective and will change, the latest BioSig Technologies (BSGM) rating was a maintained with a price target of $2.50 to $2.75. The current price BioSig Technologies (BSGM) is trading at is $1.30, which is out of the analyst’s predicted range.